-
2-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate
-
ChemBase ID:
124975
-
Molecular Formular:
C33H34N6O6
-
Molecular Mass:
610.65966
-
Monoisotopic Mass:
610.25398284
-
SMILES and InChIs
SMILES:
n1(c(nc2c1c(C(=O)OCCOC(=O)OC1CCCCC1)ccc2)OCC)Cc1ccc(c2c(c3nnn[nH]3)cccc2)cc1
Canonical SMILES:
CCOc1nc2c(n1Cc1ccc(cc1)c1ccccc1c1nnn[nH]1)c(ccc2)C(=O)OCCOC(=O)OC1CCCCC1
InChI:
InChI=1S/C33H34N6O6/c1-2-42-32-34-28-14-8-13-27(31(40)43-19-20-44-33(41)45-24-9-4-3-5-10-24)29(28)39(32)21-22-15-17-23(18-16-22)25-11-6-7-12-26(25)30-35-37-38-36-30/h6-8,11-18,24H,2-5,9-10,19-21H2,1H3,(H,35,36,37,38)
InChIKey:
NQZDOSXQAGAIAB-UHFFFAOYSA-N
-
Cite this record
CBID:124975 http://www.chembase.cn/molecule-124975.html
NAMES AND DATABASE IDS
NAMES AND DATABASE IDS
Names Database IDs
IUPAC name
|
2-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate
|
|
|
IUPAC Traditional name
|
2-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-3-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1,3-benzodiazole-4-carboxylate
|
2-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylate
|
|
|
Synonyms
|
2-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
|
Candesartan Cilexetil
|
|
|
CAS Number
|
|
PubChem SID
|
|
PubChem CID
|
|
DATA SOURCES
DATA SOURCES
All Sources Commercial Sources Non-commercial Sources
CALCULATED PROPERTIES
CALCULATED PROPERTIES
JChem
Acid pKa
|
4.2330327
|
H Acceptors
|
8
|
H Donor
|
1
|
LogD (pH = 5.5)
|
6.063863
|
LogD (pH = 7.4)
|
5.5917697
|
Log P
|
7.1918874
|
Molar Refractivity
|
177.7682 cm3
|
Polarizability
|
66.53383 Å3
|
Polar Surface Area
|
143.34 Å2
|
Rotatable Bonds
|
14
|
Lipinski's Rule of Five
|
false
|
REFERENCES
REFERENCES
From Suppliers
Google Scholar
PubMed
Google Books
- • Eur. Pat., 1991, Takeda, 459 136; CA, 116, 128924, (synth, pharmacol)
- • Mizuno, K. et al., Life Sci., 1992, 51, PL183, (Candesartan cilexitil)
- • Kubo, K. et al., J. Med. Chem., 1993, 36, 2182; 2343, (synth, pmr, ir, pharmacol)
- • Shibouta, Y. et al., J. Pharmacol. Exp. Ther., 1993, 266, 114, (pharmacol)
- • Morimoto, S. et al., Cardiovasc. Drug Rev., 1994, 12, 153, (rev)
- • Arakawa, K. et al., J. Hypertens., Suppl. 9, 1994, 12, (pharmacol, rev)
- • Flesch, M. et al., Eur. J. Pharmacol., 1995, 289, 399, (pharmacol)
- • Delacrtaz, E. et al., Hypertension (Dallas), 1995, 25, 14, (pharmacol, man)
- • Lee, J.W. et al., J. Chromatogr., B: Biomed. Appl., 1995, 670, 287, (hplc)
- • McClellan, K.J. et al., Drugs, 1998, 56, 847-869, (rev)
- • Matsunaga, H. et al., Chem. Pharm. Bull., 1999, 47, 182-186, (Candesartan ciloxetil, cmr, cryst struct)
- • Drugs of Today (Barcelona), 1999, 35, 11-16; 105-115; 117-126
- Searching...Please wait...
PATENTS
PATENTS
PubChem Patent
Google Patent